Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September

Eli Lilly and Co could have a drug specifically designed to treat COVID-19 licensed for use as early as September if all goes well with either of the two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.

Lilly is also doing preclinical studies of a third antibody treatment for the disease caused by the new coronavirus that could enter human clinical trials in the coming weeks, chief scientific officer Daniel Skovronsky said in an interview.

Lilly has already launched human trials with two of the experimental therapies.

The drugs belong to a class of biotech drugs called monoclonal antibodies widely used to treat cancer, rheumatoid arthritis, and many other conditions. A monoclonal antibody drug developed against COVID-19 is likely to be more effective than the reused drugs currently being tested against the virus.

From NDTV News